Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,939 | 1,240 | 1,050 | 900 | 700 |
| TOTAL | $1,939 | $1,240 | $1,050 | $900 | $700 |
| Non-Current Assets | |||||
| Investments And Advances | 7,080 | 5,930 | 3,510 | 0 | 0 |
| Other Non-Current Assets | 14,704 | 13,000 | 14,130 | 20,300 | 20,490 |
| TOTAL | $21,784 | $18,930 | $17,640 | $20,300 | $20,490 |
| Total Assets | $23,723 | $20,170 | $18,690 | $21,200 | $21,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,160 | 1,770 | 1,720 | 2,100 | 1,090 |
| Accrued Expenses | 9,992 | 10,670 | 10,500 | 7,220 | 4,740 |
| Other current liabilities | 14,855 | 14,060 | 15,340 | 16,070 | 14,120 |
| TOTAL | $28,007 | $26,500 | $27,560 | $25,960 | $20,760 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,099 | 4,550 | 1,850 | 1,800 | 1,620 |
| TOTAL | $7,540 | $4,550 | $1,850 | $2,470 | $2,870 |
| Total Liabilities | $35,547 | $31,050 | $29,410 | $28,430 | $23,630 |
| Shareholders' Equity | |||||
| Common Shares | 13 | 10 | 10 | 10 | 10 |
| Other shareholders' equity | 461 | -500 | 30 | 130 | 80 |
| TOTAL | $65,482 | $67,040 | $67,000 | $65,870 | $61,690 |
| Total Liabilities And Equity | $101,029 | $98,090 | $96,410 | $94,300 | $85,320 |